Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
NXT2B AB is a venture capital firm founded in 2011 by Bengt Ågerup and is based in Uppsala, Sweden. The firm focuses on growth equity investments and has backed over 30 companies since its inception. NXT2B primarily targets sectors such as healthcare, medical devices, and specialty pharmaceuticals.
NXT2B specializes in growth equity investments in healthcare, medical devices, specialty pharmaceuticals, technology, and consumer products. The firm seeks early-phase projects that exhibit high scientific quality and viable business opportunities. Typical investments are aimed at companies that are poised for significant growth.
Notable portfolio companies include AllgoHolding AB, Hansa Biopharma AB, Lokon Pharma AB, Lumina Adhesives AB, Navinci Diagnostics AB, Q-linea AB, Repos Pharma AB, Scint-X AB, and Vivolux AB.
Email your pitch deck to info@nxt2b.com for consideration.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.